Universe Pharmaceuticals INC
UPC Healthcare Drug Manufacturers Specialty & Generic
Universe Pharmaceuticals INC’s revenue for fiscal 2025 (year ended September 2025) was $17.9 million, down 22.4% from fiscal 2024.
Follow UPC
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '24 | Mar '25 | Sep '25 | Mar '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
29.50 | 47.27 | 33.59 | 29.05 |
Receivables |
18.57 | 13.53 | 15.29 | 22.14 | |
Inventory |
1.74 | 3.57 | 2.19 | 1.98 | |
Other current assets |
1.83 | 0.66 | 2.53 | 2.00 | |
Total current assets |
51.64 | 65.03 | 53.60 | 55.21 | |
Property, Plant, Equpment (Net) |
10.23 | 3.29 | 10.49 | 3.79 | |
Long-Term Investments |
0.71 | 0.69 | 0.70 | 0.72 | |
Goodwill and Intangible Assets (Total) |
0.26 | 0.27 | 0.30 | 0.31 | |
Long-term assets (Other) |
11.77 | 11.40 | 11.12 | 11.43 | |
Total non-current assets |
22.98 | 12.35 | 22.60 | 16.26 | |
Total Assets |
67.95 | 80.67 | 69.30 | 71.47 | |
Accounts Payable |
4.92 | 7.40 | 1.67 | 3.75 | |
Accrued Expenses |
1.62 | 1.65 | 0.26 | 0.25 | |
Current Part of Debt |
5.86 | 5.66 | 9.26 | 7.38 | |
Current Part of Capital Lease |
0.00 | — | 0.00 | — | |
Current Part of Taxes to Pay |
1.02 | 0.12 | 0.64 | 0.66 | |
Other current liabilities |
6.90 | 8.59 | 1.34 | 0.04 | |
Total current liabilities |
20.31 | 23.42 | 13.17 | 13.65 | |
Long Term Debt (Total) |
2.14 | 2.07 | — | 2.17 | |
Non-current Revenue (Deferred) |
0.00 | — | 0.00 | — | |
Minority Interests |
0.00 | — | 0.00 | — | |
Total non-current liabilities |
2.14 | 2.07 | — | 2.17 | |
Total liabilities |
22.45 | 25.48 | 13.17 | 15.82 | |
Additional Paid In Capital |
53.87 | 63.01 | 63.01 | 69.35 | |
Preferred Stock (Total) |
0.00 | — | 0.00 | — | |
Common Stock (Net) |
0.48 | 6.34 | 6.34 | 0.00 | |
Retained Earnings |
(10.17) | (13.46) | (13.84) | (15.40) | |
Treasury Stock |
0.00 | — | 0.00 | — | |
Shareholders Equity (Other) |
1.33 | (0.71) | 0.63 | 2.44 | |
Common Equity (Total) |
45.50 | 55.19 | 56.13 | 55.65 | |
Shareholders Equity (Total) |
45.50 | 55.19 | 56.13 | 55.65 | |
Shareholders Equity and Liabilities (Total) |
67.95 | 80.67 | 69.30 | 71.47 | |
Shares (Common) |
— | 0.56 | — | 0.56 | |
Shareholders Equity (Tangible) |
45.24 | 54.92 | 55.83 | 55.34 | |
Net Debt |
(21.50) | (39.54) | (24.33) | (19.50) | |
Total Debt |
7.99 | 7.73 | 9.26 | 9.55 |